Abstract:The genome, whose stability is essential for survival, is incessantly exposed to internal and external stressors, which introduce an estimated 104 to 105 lesions, such as oxidation, in the nuclear genome of each mammalian cell each day. A delicate homeostatic balance between the generation and repair of DNA lesions maintains genomic stability. To initiate transcription, DNA strands unwind to form a transcription bubble and provide a template for the RNA polymerase II (RNAPII) complex to synthesize nascent RNA. The process generates DNA supercoils and introduces torsional stress. To enable RNAPII processing, the supercoils are released by topoisomerases by introducing strand breaks, including double-stranded breaks (DSBs). Thus, DSBs are intrinsic genomic features of gene expression. The breaks are quickly repaired upon processing of the transcription. DNA lesions and damaged proteins involved in transcription could impede the integrity and efficiency of RNAPII processing. The impediment, which is referred to as transcription stress, not only could lead to the generation of aberrant RNA species but also the accumulation of DSBs. The latter is particularly the case when topoisomerase processing and/or the repair mechanisms are compromised. The DSBs activate the DNA damage response (DDR) pathways to repair the damaged DNA and/or impose cell cycle arrest and cell death. In addition, the release of DSBs into the cytosol activates the cytosolic DNA-sensing proteins (CDSPs), which along with the nuclear DDR pathways induce the expression of senescence-associated secretory phenotype (SASP), cell cycle arrest, senescence, cell death, inflammation, and aging. The primary stimulus in hereditary cardiomyopathies is a mutation(s) in genes encoding the protein constituents of cardiac myocytes; however, the phenotype is the consequence of intertwined complex interactions among numerous stressors and the causal mutation(s). Increased internal DNA stressors, such as oxidation, alkylation, and cross-linking, are expected to be common in pathological conditions, including in hereditary cardiomyopathies. In addition, dysregulation of gene expression also imposes transcriptional stress and collectively with other stressors provokes the generation of DSBs. In addition, the depletion of nicotinamide adenine dinucleotide (NAD), which occurs in pathological conditions, impairs the repair mechanism and further facilitates the accumulation of DSBs. Because DSBs activate the DDR pathways, they are expected to contribute to the pathogenesis of cardiomyopathies. Thus, interventions to reduce the generation of DSBs, enhance their repair, and block the deleterious DDR pathways would be expected to impart salubrious effects not only in pathological states, as in hereditary cardiomyopathies but also aging.

Targeting DNA Damage Response in Cardiovascular Diseases: from Pathophysiology to Therapeutic Implications

The Roles of DNA Damage Response Machineries in Maintaining Genome Stability&Cellular Homeo-stasis

DNA damage response, a double-edged sword for vascular aging

DNA damage response defects in hematologic malignancies: mechanistic insights and therapeutic strategies

Targeting the DNA damage response in hematological malignancies

DNA Damage Response and Immune Defense

The crosstalk between DNA-damage responses and innate immunity

DNA sensors in metabolic and cardiovascular diseases: Molecular mechanisms and therapeutic prospects

Advancing cancer therapy: new frontiers in targeting DNA damage response

DNA Damage Response in Quiescent Hematopoietic Stem Cells and Leukemia Stem Cells.

DNA damage repair and cancer immunotherapy

Targeting DNA Repair Pathways: Mechanisms and Potential Applications in Cancer Therapy

Telomere-related DNA damage response pathways in cancer therapy: prospective targets

When DNA damage responses meet tumor immunity: From mechanism to therapeutic opportunity

When DNA-damage responses meet innate and adaptive immunity

Targeting DNA damage response pathways in cancer

Targeting DNA damage response deficiency in the treatment of breast cancer

Recent Progress in DNA Damage Response-Targeting PROTAC Degraders

Causes and consequences of DNA double-stranded breaks in cardiovascular disease

DNA damage response in breast cancer and its significant role in guiding novel precise therapies

The mechanistic role of cardiac glycosides in DNA damage response and repair signaling